Viveka Roychowdhury
Calling all Healthcare Senators…
The healthcare sector in India has many pain points but that is precisely why it has attracted so much attention from entrepreneurs, both new age start-ups, as well as the old world players
Thriving through change
A recently released analysis of the global courier industry from 2010-2021, shows that the pharmaceutical sector accounts for just seven per cent of the sector's global revenue stream, which was an estimated $3.55 billion in
GST is likely to bring down total cost as a percentage of sales by 1 – 1.5%
India’s Logistics Performance Index (LPI) rank improved 19 places as per the LPI 2016 World Bank report and is set to improve further as the Goods and Service Tax (GST) bill is implemented. Vidhyasagar L, Asst General Manag
Testing the new FDI norms
The Modi government’s reforms have tinkered with FDI norms twice, first in November 2015 and more recently in June this year
‘Cost management is like the spine of the healthcare industry’
BLK Super Speciality Hospital recently bagged an Excellence Award from the Institute of Cost Accountants of India for its unique costing and business analysis systems. Latesh Sen, GM, Costing and Business Analysis, Radiant Li
Public good or publicity stunt?
One man's medicine is another man's poison
Race Against Time
Pharma companies across the world are racing against time to meet the November 2017 deadline of the US DSCSA followed by the February 2019 deadline of the EU Delegated Act. Are Indian companies ready for the complexities
Turning threat into opportunity
It is human nature to perceive change as a threat. But turning this threat into an opportunity is a crucial skill
Tarnea Technologies’ SmartMile SaaS platform to launch in Mumbai on July 22
Aims to bring automation to the 'last mile' in the pharma retail trade, targets to be in 12 states by the end of this fiscal
Back to the basics
After taking a beating from overseas regulators for the past few years, analysts are finally sounding marginally cautious about the fortunes of pharma companies in India
India’s action plan to tackle AMR
Too much of a good thing is generally bad for you. And in the case of antibiotics, could even kill you
A Clash of IPR Cultures
India’s recently released national IPR policy has spurred fresh sparring between various lobbies. As international pressure to fall in line mounts, will ‘Creative India, Innovative India’ remain a slogan? By Viveka Royc
Redrawing the Lakshman rekha
A national IPR policy, new FDI norms, a possible revamp of the Drugs & Cosmetics Act, Brexit: the pharma sector in India has a lot to chew on
M&As ka Side Effects
Indian pharma companies have notched up some aggressive global buys recently but the sector's experience with cross border M&As has been mixed. Are they on the right track this time? And how will companies deal with the possi
‘India market is very important to us’
The number of Indian companies investing in Ireland through IDA Ireland has doubled in the last three years, from 15 companies in 2013 to around 30 today but John Conlon, Executive Vice President - Asia Pacific, IDA Ireland w
Betting big on M&As
Dr Reddy's Laboratories' June 11 announcement that it had entered into an agreement with Teva and Allergan to buy eight Abbreviated New Drug Applications (ANDAs) for $350 million is the latest in a series of global buys by bi
Regulating the regulators
The Supreme Court’s decision in end May to mandate a single national entrance exam for UGH and PG medical seats from next year, has merely postponed the debate on medical education
‘There will be a shakeout in the CDMO industry’
Swedish Recipharm has been on an acquisition spree, buying out Italian CDMO, Mitim Srl in February, and completing acquisition of India-based Nitin Life Sciences and announcing another deal with Kemwell in April. Viveka Roych
Moving up the green ladder
As the Modi Government launches its second anniversary celebration on May 26, the BJP will be organising 200 odd events over a fortnight, accompanied by a social media blitz
Chennai will house more than 60 per cent of AstraZeneca’s global IT workforce
Pharma major, AstraZeneca has set up its first insourced IT facility, The Global Technology Centre (GTC) in Chennai. David Smoley, Chief Information Officer, AstraZeneca speaks on the successes of the GTC from launch to date,
‘The companies who export must comply with the regulations of the importing country’
Sudhanshu Pandey, Joint Secretary, Department of Commerce, Ministry of Commerce & Industry, Government of India takes some tough questions from Viveka Roychowdhury on the sidelines of the recently held iPHEX 2016. Now in its
Embracing quality as an opportunity
Concerned with declining pharma exports in the recent past, the Ministry of Commerce & Industry has tried to burnish the brand image of India's pharmaceutical sector
“There will be a shakeout in the CDMO industry”
Swedish Recipharm has been on an acquisition spree, buying out Italian CDMO, Mitim Srl in February, and completing acquisition of India-based Nitin Life Sciences and announcing another deal with Kemwell in April. Viveka Roych
‘We have to strike our own balance’
Sudhanshu Pandey, Joint Secretary, Department of Commerce, Ministry of Commerce & Industry, Government of India takes some tough questions from Viveka Roychowdhury on the sidelines of the recently held iPHEX 2016. Now in
Right time for IPOs?
As we go to press in end April, Dr A Velumani's Thyrocare Technologies (Thyrocare) looks set to have a successful debut on the Indian stock exchange
‘India is the hub of our global delivery network of services’
Reportedly the world's largest CRO, 34-year-old Quintiles has been through many phases. As its founder Dennis Gillings, CBE makes his farewell rounds of the company's global locations, his successor Tom Pike, CEO, talks about
To switch or not to switch …
A notice dated March 30 from the Drug Controller General (India) asking for ‘science-based suggestions/ comments’ on the pros and cons of replacing animal-based gelatin capsules with cellulose-based capsules has pharma c
Advertisement
Most Read
- March credit growth to small businesses lowest in 10 months; MSE gross bank credit share dips further
- Never exported vaccines at cost of people in India: Serum Institute
- SPACs: Flavour of the season or real opportunity for entrepreneurs to approach public markets?
- Michael Burry of ‘Big Short’ fame takes on Elon Musk; bets half a billion dollars against Tesla
- E-commerce store builder Dukaan to help SMEs deliver orders as well; partners with Dunzo, Shiprocket
- Covid Live: Delhi CM announces Rs 50,000 ex-gratia to families who lost member to Covid; Maharashtra reports 28,438 new cases
- Why are banks deducting Rs 330 from your savings account in May?
- CGTMSE: MSE loans approved in Covid-hit FY21 second highest in 7 years despite 26% YoY decline
- Why is share market resilient in face of Covid-19? Kalpen Parekh reveals; says, watch these stocks | INTERVIEW
- Sensex, Nifty extend rally to second day; are benchmark indices headed towards fresh all-time highs?
Advertisement
Top News
- March credit growth to small businesses lowest in 10 months; MSE gross bank credit share dips further
- Never exported vaccines at cost of people in India: Serum Institute
- SPACs: Flavour of the season or real opportunity for entrepreneurs to approach public markets?
- Michael Burry of ‘Big Short’ fame takes on Elon Musk; bets half a billion dollars against Tesla
- E-commerce store builder Dukaan to help SMEs deliver orders as well; partners with Dunzo, Shiprocket
- Covid Live: Delhi CM announces Rs 50,000 ex-gratia to families who lost member to Covid; Maharashtra reports 28,438 new cases
- Why are banks deducting Rs 330 from your savings account in May?
- CGTMSE: MSE loans approved in Covid-hit FY21 second highest in 7 years despite 26% YoY decline
- Why is share market resilient in face of Covid-19? Kalpen Parekh reveals; says, watch these stocks | INTERVIEW
- Sensex, Nifty extend rally to second day; are benchmark indices headed towards fresh all-time highs?
Advertisement
